当前位置：首页>产品中心>单抗/多抗>Anti-Human CD265/TNFRSF11A Polyclonal Antibody|抗人CD265/TNFRSF11A多克隆抗体(靶标：人肿瘤坏死因子受体超家族成员11A/RANK/CD265)
Anti-Human CD265/TNFRSF11A Polyclonal Antibody|抗人CD265/TNFRSF11A多克隆抗体(靶标：人肿瘤坏死因子受体超家族成员11A/RANK/CD265)
- 货号：RB9THV008014
- 价格：面议
- 点击：277
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | CD265, ODFR, Osteoclast differentiation factor receptor, RANK, Receptor activator of NF-KB, TNFRSF11A, Tumor necrosis factor receptor superfamily member 11A |
| 免疫原 | E. coli - derived recombinant Human CD265/TNFRSF11A (Ser36-Ser195). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | Q9Y6Q6 |
| 背景信息 | Tumor necrosis factor receptor superfamily member 11A (CD265/TNFRSF11A) is a ~66 kDa protein. Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis. Its interaction with EEIG1 promotes osteoclastogenesis via facilitating the transcription of NFATC1 and activation of PLCG2. Involved in the regulation of interactions between T-cells and dendritic cells. 1. Nakagawa, N. et al. (1998) Biochemical and biophysical research communications 253, 395-400. PMID: 9878548 |
| 备注 | For research use only |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 5936 |
| 磺胺氯吡嗪单抗 | 5925 |
| 呋喃苯烯酸钠单抗 | 5711 |
| 呋喃它酮代谢物（2-NPAMOZ）单抗 | 5720 |
| 呋喃西林代谢物（2-NPSEM）单抗 | 5544 |
| 磺胺喹恶啉单抗 | 5819 |
| 苯丙酸诺龙单抗 | 5722 |
| 司帕沙星单抗 | 5575 |
| 妥布霉素单抗 | 5734 |
| 甲氧氯普胺单抗 | 5563 |
| 莫能菌素单抗 | 5724 |
| 多粘菌素B（粘菌素）单抗 | 6060 |
| 磺胺类单抗 | 5966 |
| 托灭酸（托芬那酸）单抗 | 5595 |
| 卡洛芬单抗 | 5541 |
| 喹乙醇代谢物MQCA单抗 | 5709 |
| 氟尼辛单抗 | 5716 |
| 磺胺二甲嘧啶（SM2）单抗 | 5448 |
| 诺龙（19-去甲睾酮）单抗 | 5549 |
| 阿苯达唑-2-氨基砜单抗 | 5478 |
